Bleomycin

SMAD family member 3 ; Mus musculus







29 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35187969 Protective effects of alpha-lipoic acid on bleomycin-induced skin fibrosis through the repression of NADPH Oxidase 4 and TGF-β1/Smad3 signaling pathways. 2022 Jan-Dec 1
2 33922418 Echinochrome A Treatment Alleviates Fibrosis and Inflammation in Bleomycin-Induced Scleroderma. 2021 Apr 23 1
3 34142927 Glycyrrhizic acid, as an inhibitor of HMGB1, alleviates bleomycin-induced pulmonary toxicity in mice through the MAPK and Smad3 pathways. 2021 Aug 2
4 34666752 Dual inhibition of αvβ6 and αvβ1 reduces fibrogenesis in lung tissue explants from patients with IPF. 2021 Oct 19 1
5 35126110 Wenfei Buqi Tongluo Formula Against Bleomycin-Induced Pulmonary Fibrosis by Inhibiting TGF-β/Smad3 Pathway. 2021 1
6 31940650 Ganoderic Acid A Inhibits Bleomycin-Induced Lung Fibrosis in Mice. 2020 1
7 33101446 Feibi Recipe Reduced Pulmonary Fibrosis Induced by Bleomycin in Mice by Regulating BRP39/IL-17 and TGFβ1/Smad3 Signal Pathways. 2020 1
8 29926545 The Effects of Retinoic Acid and MAPK Inhibitors on Phosphorylation of Smad2/3 Induced by Transforming Growth Factor β1. 2019 Jan 1
9 31108104 Progranulin Promotes Bleomycin-Induced Skin Sclerosis by Enhancing Transforming Growth Factor-β/Smad3 Signaling through Up-Regulation of Transforming Growth Factor-β Type I Receptor. 2019 Aug 1
10 31775746 Vitamin D deficiency exacerbates bleomycin-induced pulmonary fibrosis partially through aggravating TGF-β/Smad2/3-mediated epithelial-mesenchymal transition. 2019 Nov 27 3
11 29913150 SIS3, a specific inhibitor of smad3, attenuates bleomycin-induced pulmonary fibrosis in mice. 2018 Sep 5 1
12 30470612 Evaluation of the antifibrotic potency by knocking down SPARC, CCR2 and SMAD3. 2018 Dec 1
13 27777101 Glycyrrhizin Ameliorates Fibrosis, Vasculopathy, and Inflammation in Animal Models of Systemic Sclerosis. 2017 Mar 1
14 28263294 Increased expression of latent TGF-β-binding protein 4 affects the fibrotic process in scleroderma by TGF-β/SMAD signaling. 2017 May 2
15 28533545 Treatment effects of the traditional Chinese medicine Shenks in bleomycin-induced lung fibrosis through regulation of TGF-beta/Smad3 signaling and oxidative stress. 2017 May 22 1
16 28694203 Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways. 2017 Aug 15 1
17 25356121 Dexamethasone attenuates bleomycin-induced lung fibrosis in mice through TGF-β, Smad3 and JAK-STAT pathway. 2014 1
18 23161884 TGF-β-Smad3 signaling in emphysema and pulmonary fibrosis: an epigenetic aberration of normal development? 2013 Jan 15 1
19 22395530 miR-29 inhibits bleomycin-induced pulmonary fibrosis in mice. 2012 Jun 1
20 22398790 Sequential analysis of myofibroblast differentiation and transforming growth factor-β1/Smad pathway activation in murine pulmonary fibrosis. 2012 4
21 22687409 Mutant soluble ectodomain of fibroblast growth factor receptor-2 IIIc attenuates bleomycin-induced pulmonary fibrosis in mice. 2012 1
22 18976720 VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice. 2009 Jan 1
23 17303001 Effect of TGF-beta/Smad signaling pathway on lung myofibroblast differentiation. 2007 Mar 2
24 16438734 EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-beta signaling in lung fibroblasts. 2006 Jan 27 1
25 17065376 Smad3 signaling involved in pulmonary fibrosis and emphysema. 2006 Nov 1
26 15154911 Smad3 as a mediator of the fibrotic response. 2004 Apr 1
27 15215176 Targeted disruption of TGF-beta/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma. 2004 Jul 2
28 12839562 Sustained activation of fibroblast transforming growth factor-beta/Smad signaling in a murine model of scleroderma. 2003 Jul 1
29 11839555 Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice. 2002 Mar 5